Follow
AYLIN DOMANIKU
AYLIN DOMANIKU
Ph.D. candidate
Verified email at ku.edu.tr
Title
Cited by
Cited by
Year
Altered perivascular fibroblast activity precedes ALS disease onset
A Månberg, N Skene, F Sanders, M Trusohamn, J Remnestål, ...
Nature medicine 27 (4), 640-646, 2021
902021
EDA2R–NIK signalling promotes muscle atrophy linked to cancer cachexia
SN Bilgic, A Domaniku, B Toledo, S Agca, BZC Weber, DH Arabaci, ...
Nature 617 (7962), 827-834, 2023
192023
Inhibition of epidermal growth factor receptor suppresses parathyroid hormone‐related protein expression in tumours and ameliorates cancer‐associated cachexia
BZC Weber, S Agca, A Domaniku, SN Bilgic, DH Arabaci, S Kir
Journal of cachexia, sarcopenia and muscle 13 (3), 1582-1594, 2022
142022
Muscle wasting: emerging pathways and potential drug targets
A Domaniku, SN Bilgic, S Kir
Trends in Pharmacological Sciences, 2023
62023
Activated Oncostatin M signaling drives cancer-associated skeletal muscle wasting
A Domaniku, S Agca, B Toledo, SN Bilgic, AE Kashgari, S Kir
BioRxiv, 2023.01. 26.525658, 2023
22023
EDA2R/NIK signaling promotes skeletal muscle atrophy linked to cancer cachexia
S Nur Bilgic, A Domaniku, B Toledo, S Agca, BZC Weber, DH Arabaci, ...
bioRxiv, 2023.01. 23.525138, 2023
12023
Altered perivascular fibroblast activity precedes ALS disease onset (vol 27, pg 640, 2021)
A Manberg, N Skene, F Sanders, M Trusohamn, J Remnestal, ...
NATURE MEDICINE 27 (7), 1308-1308, 2021
12021
Effect of Gemcitabine on HOTAIR Expression Level in H596 and H1944 Cell Lines
E Kandemiş, A Domaniku, İ Polat, G Bulut
Proceedings 2 (25), 1590, 2018
2018
The system can't perform the operation now. Try again later.
Articles 1–8